BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2453712)

  • 1. [Preparation of lyophilized reagents for determining the functional activity of complement C1, C2, C3, C4 and C5 components].
    Nikiforova TV; Kuznetsova NN; Vavilova LM
    Lab Delo; 1988; (3):28-31. PubMed ID: 2453712
    [No Abstract]   [Full Text] [Related]  

  • 2. The functional significance of complement.
    Fearon DT; Ruddy S; Knostman JD; Carpenter CB; Austen KF
    Adv Nephrol Necker Hosp; 1974; 4():15-35. PubMed ID: 4219991
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement and mesangiocapillary glomerulonephritis: the role of complement deficiency in glomerulonephritis.
    Peters DK; Williams DG
    Adv Nephrol Necker Hosp; 1974; 4():67-78. PubMed ID: 4220000
    [No Abstract]   [Full Text] [Related]  

  • 4. The complement system and nephritis.
    Müller-Eberhard HJ
    Adv Nephrol Necker Hosp; 1974; 4():3-14. PubMed ID: 4143384
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemistry and function of the complement system.
    Müller-Eberhard HJ
    Hosp Pract; 1977 Aug; 12(8):33-43. PubMed ID: 892784
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
    Leddy JP; Simons RL; Douglas RG
    J Immunol; 1977 Jan; 118(1):28-34. PubMed ID: 187701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of complement in human nephritis.
    Lambert PH; Perrin LH; Mahieu P; Nydegger UE; Miescher PA
    Adv Nephrol Necker Hosp; 1974; 4():79-90. PubMed ID: 4220001
    [No Abstract]   [Full Text] [Related]  

  • 8. C1, C4, and C2 components of the classical pathway of complement and regulatory proteins.
    Gigli I; Tausk FA
    Methods Enzymol; 1988; 162():626-39. PubMed ID: 3226327
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for activation of the alternate pathway in glomerulonephritis.
    Michael AF; McLean RH
    Adv Nephrol Necker Hosp; 1974; 4():49-66. PubMed ID: 4219999
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-mediated bactericidal system: evidence for a new pathway of complement action.
    Moreau SC; Skarnes RC
    Science; 1975 Oct; 190(4211):278-80. PubMed ID: 1101380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the early components of the classical complement pathway under physiologic conditions.
    Ziccardi RJ
    J Immunol; 1981 May; 126(5):1769-73. PubMed ID: 7217665
    [No Abstract]   [Full Text] [Related]  

  • 13. The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor.
    Ji YH; Matsushita M; Okada H; Fujita T; Kawakami M
    J Immunol; 1988 Dec; 141(12):4271-5. PubMed ID: 3058802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
    Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
    J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C5a: a mediator of chemotaxis and cellular release reactions.
    Gerard C; Hugli TE
    Kroc Found Ser; 1981; 14():147-60. PubMed ID: 6975805
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of induction of IL-1 production in human monocytes by complement fragments.
    Arend WP; Massoni RJ; Niemann MA; Giclas PC
    J Immunol; 1989 Jan; 142(1):173-8. PubMed ID: 2783323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple methods for preparing EAC1,4b,2a,3b and EAC4b,3b with human or guinea pig complement components using an anticomplementary agent, K-76 monocarboxylic acid.
    Hong K; Kinoshita T; Inoue K
    J Immunol; 1981 Jul; 127(1):109-14. PubMed ID: 6909271
    [No Abstract]   [Full Text] [Related]  

  • 18. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of complement consumption by atopic allergens.
    Berrens L; Van Rijswijk-Verbeek J; Guikers CL
    Immunochemistry; 1976 May; 13(5):367-72. PubMed ID: 939579
    [No Abstract]   [Full Text] [Related]  

  • 20. Developmental aspects of complement components in the newborn. The presence of complement components and C3 proactivator (properdin factor B) in human colostrum.
    Ballow M; Fang F; Good RA; Day NK
    Clin Exp Immunol; 1974 Oct; 18(2):257-66. PubMed ID: 4478765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.